Topas Therapeutics
GermanyEntry
2017
Hold
9yr
Status
Active
Who owns Topas Therapeutics?
Topas Therapeutics is currently owned by Boehringer Ingelheim Venture Fund through Boehringer Ingelheim Venture Fund (2010 vintage), since 2017. Across its history, Topas Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Boehringer Ingelheim Venture FundBoehringer Ingelheim Venture Fund · 2010 · Evergreen
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods
Active
GimvActive
present · Gimv Portfolio
More from Boehringer Ingelheim Venture Fund
Other portfolio companies in the same fund.
US
Switzerland
France
UKMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Topas Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Topas Therapeutics?
1 strategic and 119financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Topas Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue